Study Overview The study aimed to evaluate the effectiveness of combining rituximab and intravenous immunoglobulin (IVIG) therapy alongside plasma exchange […]
Study Overview This retrospective study examines the effectiveness of combining rituximab and intravenous immunoglobulin (IVIG) with plasma exchange in treating
Mechanisms of Autoimmune Regulation The understanding of autoimmune regulation mechanisms is crucial to unraveling the complexities of diseases like multiple
Study Overview The investigation focused on remibrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor, and its potential applications in treating
Investigations of remibrutinib in models pertinent to multiple sclerosis Read Post »
Study Overview The investigation centered on remibrutinib, a Bruton’s tyrosine kinase inhibitor, focusing on its effects and potential benefits in
Investigations of remibrutinib in models pertinent to multiple sclerosis Read Post »
Peptide Mechanism of Action The peptide derived from telomerase exhibits a unique mechanism that appears to interact with various biological
GV1001: repurposing a telomerase-derived peptide for neurological therapeutics Read Post »
Overview of Adjunctive Therapies Adjunctive therapies in multiple sclerosis (MS) encompass a range of non-disease-modifying treatments that aim to alleviate
Study Overview This research investigates protein alterations in the cerebrospinal fluid (CSF) using two distinct models of demyelination: Experimental Autoimmune
Oxidative Signature in Multiple Sclerosis In the context of primary progressive multiple sclerosis (PPMS), the concept of an oxidative signature
Opioid Mechanisms in Multiple Sclerosis Opioids, known primarily for their pain-relieving properties, interact with specific receptors in the nervous system.
Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair Read Post »
